Hu Q, Shi Y, Wang H, Bing L, Xu Z
    
    
    Exp Hematol Oncol. 2025; 14(1):37.
  
  
    PMID: 40087690
    
    
          DOI: 10.1186/s40164-025-00627-6.
      
 
                                  
  
    Pryke L, Liu Z, Khaitan A, Sims E, Gupta S
    
    
    AIDS. 2024; 38(11):1725-1727.
  
  
    PMID: 39088830
    
          PMC: 11296497.
    
          DOI: 10.1097/QAD.0000000000003932.
      
 
                                  
  
    Chen P, Hsu W, Peng C, Liao T, Chang S, Chen H
    
    
    Front Med (Lausanne). 2024; 11:1347268.
  
  
    PMID: 38371515
    
          PMC: 10869587.
    
          DOI: 10.3389/fmed.2024.1347268.
      
 
                                  
  
    Lima G, Chura-Chambi R, Morganti L, Silva V, Cabral-Piccin M, Rocha V
    
    
    Front Bioeng Biotechnol. 2023; 11:1227212.
  
  
    PMID: 37588136
    
          PMC: 10426796.
    
          DOI: 10.3389/fbioe.2023.1227212.
      
 
                                  
  
    Das S, Dash B, Premji T, Chen J
    
    
    Int J Mol Sci. 2023; 24(13).
  
  
    PMID: 37445721
    
          PMC: 10341481.
    
          DOI: 10.3390/ijms241310546.
      
 
                              
              
                              
                                      
  Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.
  
    Li L, Xu X, Wang X, Zhang S, Yao W, Liu J
    
    
    Clin Exp Immunol. 2023; 213(2):155-163.
  
  
    PMID: 37279535
    
          PMC: 10361740.
    
          DOI: 10.1093/cei/uxad062.
      
 
                                          
                                                          
  Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis.
  
    Matsumoto H, Fujita Y, Onizawa M, Saito K, Sumichika Y, Yoshida S
    
    
    Front Immunol. 2023; 13:978435.
  
  
    PMID: 36591283
    
          PMC: 9794574.
    
          DOI: 10.3389/fimmu.2022.978435.
      
 
                                          
                                                          
  Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges.
  
    Poggi A, Zocchi M
    
    
    Mol Ther Oncolytics. 2022; 24:26-42.
  
  
    PMID: 34977340
    
          PMC: 8693432.
    
          DOI: 10.1016/j.omto.2021.11.016.
      
 
                                          
                                                          
  Association between inflammatory cytokines and immune-checkpoint molecule in rheumatoid arthritis.
  
    Matsumoto H, Fujita Y, Asano T, Matsuoka N, Temmoku J, Sato S
    
    
    PLoS One. 2021; 16(11):e0260254.
  
  
    PMID: 34793561
    
          PMC: 8601500.
    
          DOI: 10.1371/journal.pone.0260254.
      
 
                                          
                                                          
  Association of soluble T cell immunoglobulin domain and mucin-3 (sTIM-3) and mac-2 binding protein glycosylation isomer (M2BPGi) in patients with autoimmune hepatitis.
  
    Migita K, Nakamura M, Aiba Y, Kozuru H, Abiru S, Komori A
    
    
    PLoS One. 2020; 15(12):e0238540.
  
  
    PMID: 33347507
    
          PMC: 7751864.
    
          DOI: 10.1371/journal.pone.0238540.
      
 
                                          
                                                          
  Serum Levels of T Cell Immunoglobulin and Mucin-Domain Containing Molecule 3 in Patients with Systemic Lupus Erythematosus.
  
    Asano T, Matsuoka N, Fujita Y, Matsumoto H, Temmoku J, Yashiro-Furuya M
    
    
    J Clin Med. 2020; 9(11).
  
  
    PMID: 33167436
    
          PMC: 7694535.
    
          DOI: 10.3390/jcm9113563.
      
 
                                          
                                                          
  T cell immunoglobulin and mucin domain-3 is associated with disease activity and progressive joint damage in rheumatoid arthritis patients.
  
    Matsumoto H, Fujita Y, Asano T, Matsuoka N, Temmoku J, Sato S
    
    
    Medicine (Baltimore). 2020; 99(44):e22892.
  
  
    PMID: 33126340
    
          PMC: 7598883.
    
          DOI: 10.1097/MD.0000000000022892.
      
 
                                          
                                                          
  Elevated serum levels of checkpoint molecules in patients with adult Still's disease.
  
    Fujita Y, Asano T, Matsumoto H, Matsuoka N, Temmoku J, Sato S
    
    
    Arthritis Res Ther. 2020; 22(1):174.
  
  
    PMID: 32698838
    
          PMC: 7374897.
    
          DOI: 10.1186/s13075-020-02263-3.
      
 
                                          
                                                          
  The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases.
  
    Carballido J, Regairaz C, Rauld C, Raad L, Picard D, Kammuller M
    
    
    Front Immunol. 2020; 11:472.
  
  
    PMID: 32296421
    
          PMC: 7137386.
    
          DOI: 10.3389/fimmu.2020.00472.
      
 
                                          
                                                          
  Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus.
  
    Matsuoka N, Fujita Y, Temmoku J, Furuya M, Asano T, Sato S
    
    
    PLoS One. 2020; 15(1):e0227069.
  
  
    PMID: 31986153
    
          PMC: 6984724.
    
          DOI: 10.1371/journal.pone.0227069.
      
 
                                          
                                                          
  Galectin-9 in autoimmune hepatitis: Correlation between serum levels of galectin-9 and M2BPGi in patients with autoimmune hepatitis.
  
    Matsuoka N, Kozuru H, Koga T, Abiru S, Yamasaki K, Komori A
    
    
    Medicine (Baltimore). 2019; 98(35):e16924.
  
  
    PMID: 31464928
    
          PMC: 6736219.
    
          DOI: 10.1097/MD.0000000000016924.
      
 
                                          
                                                          
  FcγR-Binding Is an Important Functional Attribute for Immune Checkpoint Antibodies in Cancer Immunotherapy.
  
    Chen X, Song X, Li K, Zhang T
    
    
    Front Immunol. 2019; 10:292.
  
  
    PMID: 30863404
    
          PMC: 6399403.
    
          DOI: 10.3389/fimmu.2019.00292.
      
 
                                          
                                                          
  Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
  
    Yang H, Xie T, Li D, Du X, Wang T, Li C
    
    
    Mol Metab. 2019; 23:24-36.
  
  
    PMID: 30862474
    
          PMC: 6479760.
    
          DOI: 10.1016/j.molmet.2019.02.007.
      
 
                                          
                                                          
  Galectin-9 Alleviates LPS-Induced Preeclampsia-Like Impairment in Rats via Switching Decidual Macrophage Polarization to M2 Subtype.
  
    Li Z, Wang L, Liu H, Muyayalo K, Huang X, Mor G
    
    
    Front Immunol. 2019; 9:3142.
  
  
    PMID: 30687334
    
          PMC: 6335255.
    
          DOI: 10.3389/fimmu.2018.03142.
      
 
                                          
                                                          
  TIM-3 rs1036199 polymorphism increases susceptibility to autoimmune diseases: evidence based on 4200 subjects.
  
    Liu R, Wang X, Chen X, Wang S, Zhang H
    
    
    Biosci Rep. 2018; 38(6).
  
  
    PMID: 30377229
    
          PMC: 6250810.
    
          DOI: 10.1042/BSR20181235.